Lincoln Pharmaceuticals Limited Approved the resignation tendered by Mr. Anand A. Patel(DIN: 00103316), Whole Time Director of the Company from the position of Whole Time Director as well as Director of the Company to be made effective from May 25, 2023 after the closure of business hours. The details under Regulation 30 of SEBI (LODR) Regulations will be submitted separately.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
627 INR | +4.82% | +4.89% | -1.81% |
1st Jan change | Capi. | |
---|---|---|
-1.81% | 144M | |
+31.37% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.83% | 239B | |
+9.93% | 211B | |
-6.95% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- LINCOLN Stock
- News Lincoln Pharmaceuticals Limited
- Lincoln Pharmaceuticals Limited Approves the Resignation of Anand A. Patel from the Position of Whole Time Director as Well as Director of the Company